|
Atomistry » Chlorine » PDB 4c0n-4c8d » 4c4i | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 4c0n-4c8d » 4c4i » |
Chlorine in PDB 4c4i: Structure-Based Design of Orally Bioavailable Pyrrolopyridine Inhibitors of the Mitotic Kinase MPS1Enzymatic activity of Structure-Based Design of Orally Bioavailable Pyrrolopyridine Inhibitors of the Mitotic Kinase MPS1
All present enzymatic activity of Structure-Based Design of Orally Bioavailable Pyrrolopyridine Inhibitors of the Mitotic Kinase MPS1:
2.7.12.1; Protein crystallography data
The structure of Structure-Based Design of Orally Bioavailable Pyrrolopyridine Inhibitors of the Mitotic Kinase MPS1, PDB code: 4c4i
was solved by
S.Naud,
I.M.Westwood,
A.Faisal,
P.Sheldrake,
V.Bavetsias,
B.Atrash,
M.Liu,
A.Hayes,
J.Schmitt,
A.Wood,
V.Choi,
K.Boxall,
G.Mak,
M.Gurden,
M.Valenti,
A.De Haven Brandon,
A.Henley,
R.Baker,
C.Mcandrew,
B.Matijssen,
R.Burke,
S.A.Eccles,
F.I.Raynaud,
S.Linardopoulos,
R.Van Montfort,
J.Blagg,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Structure-Based Design of Orally Bioavailable Pyrrolopyridine Inhibitors of the Mitotic Kinase MPS1
(pdb code 4c4i). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Structure-Based Design of Orally Bioavailable Pyrrolopyridine Inhibitors of the Mitotic Kinase MPS1, PDB code: 4c4i: Chlorine binding site 1 out of 1 in 4c4iGo back to![]() ![]()
Chlorine binding site 1 out
of 1 in the Structure-Based Design of Orally Bioavailable Pyrrolopyridine Inhibitors of the Mitotic Kinase MPS1
![]() Mono view ![]() Stereo pair view
Reference:
S.Naud,
I.M.Westwood,
A.Faisal,
P.W.Sheldrake,
V.Bavetsias,
B.Atrash,
K.J.Cheung,
M.Liu,
A.Hayes,
J.Schmitt,
A.Wood,
V.Choi,
K.Boxall,
G.Mak,
M.Gurden,
M.Valenti,
A.De-Haven-Brandon,
A.Henley,
R.Baker,
C.Mcandrew,
B.Matijssen,
R.Burke,
S.Hoelder,
S.A.Eccles,
F.I.Raynaud,
S.Linardopoulos,
R.L.M.Van Montfort,
J.Blagg.
Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3, 2-C]Pyridine Inhibitors of the Mitotic Kinase Monopolar Spindle 1 (MPS1). J.Med.Chem. V. 56 10045 2013.
Page generated: Fri Jul 11 13:44:30 2025
ISSN: ISSN 0022-2623 PubMed: 24256217 DOI: 10.1021/JM401395S |
Last articlesMn in 3DT7Mn in 3DTB Mn in 3DT4 Mn in 3DSD Mn in 3DT2 Mn in 3DJ8 Mn in 3DKY Mn in 3DKX Mn in 3DIY Mn in 3D4K |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |